INTRODUCTION
============

Osteoclast-Like Giant Cells (OGC) are multinucleated large cells with clear cytoplasm and are encountered in relatively uncommon tumors of the bone tissue and the tendon sheath. Although these osseous tumors are generally benign by nature and have a slow growth, they still have a recurrence rate of over 50% and may give pulmonary metastasis.

The presence of OGC in different extra-skeletal neoplasms has been cited in various literatures \[[@b1-mjm11_2p152],[@b2-mjm11_2p152],[@b3-mjm11_2p152],[@b4-mjm11_2p152]\] with the involvement of organs including the skin, breast, pancreas, gall-bladder and the kidneys. Though the origin of these cells has been proposed to be of the mononuclear-macrophage lineage, their actual role in the histogenesis in these extra-osseous tumors is ill-defined.

In this case report we present a detailed case of a patient with gastric adeno-carcinoma with OGC. A special focus will be laid on the immune reaction in the tumor tissue of such neoplasms with a brief discussion on the differential diagnosis of such neoplasms with anaplastic carcinomas which also manifest with atypical giant nucleated cells.

CASE REPORT
===========

A 70-year-old Caucasian female was admitted to the Surgical Department of the St. Petersburg State Medical Academy with complaints of epigastric pain in May 2004. Detailed history revealed a 6-month history of nausea, epigastrial pain and progressive generalized weakness. A soft abdomen with slight epigastrial tenderness was found on palpation. Laboratory investigations showed anemia, hypoproteinemia and dysproteinemia. A fibro-oesophago-gastro-duodenoscopy revealed a stomach with relatively rigid walls. A polypoid protrusion of the gastric mucosa along with multiple erosions with a tendency to bleed in the region of the gastric cardia and the small curvature was noticed. Of the three biopsy specimens, the one obtained from the esophagus displayed signs of inflammation whereas the ones from the erosions depicted definite malignant changes corresponding to gastric adeno-carcinoma. Following diagnosis, a gastrectomy with D1 lymph node dissection and oesophago-jejunostomy with an inter-intestinal anastomosis was performed. The surgical TNM was finalized as ST3N2M0.

MACROSCOPIC FINDINGS
====================

A tumor involving the gastric cardia and small curvature was presented as a polyp like mass with distinct ulcerative changes and blood clots on its surface. Noted dimensions were 10×10×6 cm. The cut surface of the tumor revealed a whitish-pink mass that had an invasive pattern of growth and involved all the layers of the stomach wall but without any encroachment into the surrounding organs. The tumor was classified as Bor 2 according to Bormann's scale.

MICROSCOPIC FINDINGS
====================

The tumor was diagnosed as being a low differentiated adeno-carcinoma with specific stromal infiltration accompanying multinucleated giant cells and extensive lympho-histiocytic infiltration ([Figure 1](#f1-mjm11_2p152){ref-type="fig"} and [Figure 2](#f2-mjm11_2p152){ref-type="fig"}). The giant cells were predominantly located in the stroma around the malignant glands with seldom peri-glandular localization. The giant cells were characterized by a clear cytoplasm and multiple nuclei ranging between 3 to 7, arranged either circumferentially or randomly in the cytoplasm. Eight of the lymph nodes isolated from the region of the small curvature of the stomach were positive for metastases. The margins of gastrectomy presented with normal gastric tissue, thus confirming the success of the operation. The pTNM was inferred as pT3N2M0.

IMMUNOHISTOCHEMISTRY
====================

Staining for different immunohistochemical markers, listed in [Table 1](#t1-mjm11_2p152){ref-type="table"} were carried out on 6rm thick tissue samples placed on polyvinyl slides, with appropriate positive and negative controls. The Labeled Streptavidin Biotin (LSAB-DAKO) detection system was used for detection of primary antibodies.

Staining with Pan- cytokeratin ([Figure 4](#f4-mjm11_2p152){ref-type="fig"}) was strongly positive for the poorly differentiated malignant gastric glands without any staining of the intervening stromal compartment. In contrast, the stromal compartment was highly stained by the CD68 marker, whereas the staining in the malignant epithelium was almost negligible ([Figure 3](#f3-mjm11_2p152){ref-type="fig"}). Interestingly, staining with CD4 and CD8 revealed mostly stromal infiltration by the latter and dual stromal and glandular infiltration by the former.

Note that the tumor tissue, and the regional lymph nodes, were positively stained for the latent nuclear antigen of EBV. Ki67 immunostaining surprisingly showed total absence of any proliferation in the tumor tissue sample, while the anti-apoptotic marker, BCL 2, was only moderately expressed.

CONCLUSION
==========

Giant cell carcinomas of the stomach belong to a group of rare neoplasms. These neoplasms are of epithelial origin and were confirmed by positive pancytokeratin staining. Given the intense immune reaction in these tumors, and presence of multinuclear giant cells, a crucial question remains as to whether such neoplasms are more aggressive than other adenocarcinomas without such elements.

Adeno-carcinomas of the stomach with OGC have to be also carefully differentiated from anaplastic carcinomas, which are usually characterized by faster growth, early metastasis and a much poorer prognosis. Anaplastic cancer cells may present with several morphological features and may have from a single to multiple nuclei but in all cases the giant cells will be of epithelial origin and hence will stain negative to CD68 or other mesenchymal markers thus validating their epithelial nature.

Although the etiology of the lymphocytic infiltration of the tumors is not entirely known, EBV infection has been argued to be a probable cause and has been isolated in various cases of lymphoepithelioma-like tumors (LELT) \[[@b5-mjm11_2p152],[@b6-mjm11_2p152]\] . These tumors, although typical for the nasopharynx, have also been encountered in the stomach, bladder and intestinal mucosa, and are identifiable by lympho-histiocytic infiltration. Furthermore, such tumors have also been cited to have a better prognosis in comparison to GC cases without EBV infection \[[@b7-mjm11_2p152]\].

The prognostic index in this case was proposed by running immunohistochemical tests on prominent independent markers, Ki67 and Bcl2. Researchers have diverse opinions on the prognostic value of Bcl2 expression in gastric cancer \[[@b8-mjm11_2p152],[@b9-mjm11_2p152],[@b10-mjm11_2p152],[@b11-mjm11_2p152],[@b12-mjm11_2p152]\]. While traditional view connects the over-expression of Bcl2 to low tumor apoptotic ability and hence a poorer prognosis, studies have also linked the expression of Bcl2 as an indicator for biological activity of tumor \[[@b13-mjm11_2p152]\]. In our case, we see mild expression of Bcl2 and negative expression of Ki67, thus suggesting a low biological activity of the tumor i.e. higher index of apoptosis and lower proliferative index. These results must be, however, considered in the light of the advanced TNM staging, which remains the best predictor in terms of survival.

To conclude, OGC represent uncommon tumors of the stomach. The rarity with which such neoplasms present in clinical practice makes it difficult to make universal conclusions about the prognosis. They must, however, be distinguished from anaplastic carcinomas of the stomach, with a more diffuse pattern of growth and a poorer prognosis overall.
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![Moderately differentiated malignant glands with prominent lympho-histocytic infiltration of the stroma. Magnification 100X.](mjm11_2p152f1){#f1-mjm11_2p152}

![Arrow indicating stromal localization of a typical giant cell with multiple nuclei distributed circumferentially. Magnification 400X.](mjm11_2p152f2){#f2-mjm11_2p152}

![CD68 staining showing the positive staining of stromal elements with relatively free glands. Magnification 200X.](mjm11_2p152f3){#f3-mjm11_2p152}

![Positive staining of malignant glands for Pan-Cytokeratin antibodies . Magnification 200X.](mjm11_2p152f4){#f4-mjm11_2p152}

###### 

List of primary monoclonal antibodies used in immunohistochemistry.

  Antibodies   Source                                           Staining      Dilution
  ------------ ------------------------------------------------ ------------- ----------
  CD 8         [\*](#tfn2-mjm11_2p152){ref-type="table-fn"}     Membrane      RTU
  CD 4         [\*](#tfn2-mjm11_2p152){ref-type="table-fn"}     Membrane      RTU
  CD68         [\*](#tfn2-mjm11_2p152){ref-type="table-fn"}     Cytoplasmic   1:40
  PCK          [\*](#tfn2-mjm11_2p152){ref-type="table-fn"}     Cytoplasmic   RTU
  PCNA         [\*\*](#tfn3-mjm11_2p152){ref-type="table-fn"}   Nuclear       1:200
  BCL2         [\*\*](#tfn3-mjm11_2p152){ref-type="table-fn"}   Cytoplasmic   1:50
  EBV          [\*](#tfn2-mjm11_2p152){ref-type="table-fn"}     Cytoplasmic   1:100
  Ki 67        [\*\*](#tfn3-mjm11_2p152){ref-type="table-fn"}   Nuclear       

PCK-Pan- cytokeratin, EBV-Epstein Barr Virus, PCNA- Proliferating Cell Nuclear Antigen

Novocastra England

DAKO,Germany

RTU- Ready to Use antibodies
